Anavex Life Sciences
AVXL
147 hedge funds and large institutions have $161M invested in Anavex Life Sciences in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 23 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 44
7.28% more ownership
Funds ownership: 31.52% → 38.81% (+7.3%)
1% more call options, than puts
Call options by funds: $7.28M | Put options by funds: $7.19M
4% less funds holding
Funds holding: 153 → 147 (-6)
26% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 23
33% less capital invested
Capital invested by funds: $241M → $161M (-$79.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$20.6M |
| 2 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$3.94M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$3.64M |
| 4 |
Two Sigma Investments
New York
|
+$2.75M |
| 5 |
Citigroup
New York
|
+$2.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
-$2.86M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.36M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.54M |
| 4 |
Morgan Stanley
New York
|
-$628K |
| 5 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$555K |
AVXL Hedge Fund Activity: Q1 2024 in Review
147 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q1 2024, worth a combined $161M — down 33% from $241M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of AVXL and 17 opened new positions — a net loss of 6 holders — while 44 trimmed existing stakes and 52 added.
The largest buyer was State Street, adding an estimated $20.6M. The largest seller was SG Americas Securities, exiting entirely with an estimated $2.86M sold.
- 147 institutional investors held Anavex Life Sciences (AVXL) as of Q1 2024, down from 153 in Q4 2023.
- Funds reported $161M of Anavex Life Sciences stock for Q1 2024, down 33% quarter-over-quarter.
- 17 funds opened new Anavex Life Sciences positions in Q1 2024 and 23 closed out, a net change of -6 holders.
- The largest Anavex Life Sciences buyer in Q1 2024 was State Street, an estimated $20.6M added.
- The largest Anavex Life Sciences seller in Q1 2024 was SG Americas Securities, an estimated $2.86M sold.
Based on aggregated 13F filings for Q1 2024.